{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:33:40Z","timestamp":1792805620543,"version":"4.5.0"},"reference-count":155,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hospital General de Granollers","id":[{"id":"https:\/\/ror.org\/0190kj665","id-type":"ROR","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/0190kj665","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Pulmonary fibrosis, encompassing idiopathic pulmonary fibrosis (IPF) and other fibrosing interstitial lung diseases (ILDs) with a progressive phenotype (PPF), represents a group of chronic, life-threatening conditions associated with significant morbidity, mortality, and socioeconomic burden. Despite advances in antifibrotic therapies, traditional disease-centered management alone is insufficient to address the multidimensional needs of affected patients. This comprehensive review advocates for a holistic, patient-centered approach to the management of pulmonary fibrosis, integrating pharmacological interventions with systematic comorbidity assessment, pulmonary rehabilitation, psychosocial support, nutritional optimization, early palliative care, social and community reinforcement, and digital health technologies. We examine the evidence supporting each dimension of holistic care, discuss current barriers to implementation\u2014including healthcare fragmentation, limited multidisciplinary protocols, and scarce resources\u2014and outline future perspectives centered on precision medicine and integrated care models. By shifting from a purely organ-focused paradigm to a comprehensive, multidisciplinary strategy, clinicians can improve not only disease outcomes but also quality of life and overall well-being for patients living with fibrosing ILDs.<\/jats:p>","DOI":"10.3390\/medicina62050817","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:26:18Z","timestamp":1777051578000},"page":"817","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Holistic Management of Pulmonary Fibrosis: A Comprehensive Review"],"prefix":"10.3390","volume":"62","author":[{"given":"In\u00e9s","family":"Palacio","sequence":"first","affiliation":[{"name":"Pulmonology Department, Hospital Clinic, 08402 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5113-4285","authenticated-orcid":false,"given":"Fernanda","family":"Hern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Pulmonology Department, Hospital Clinic, 08402 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5403-5688","authenticated-orcid":false,"given":"Jacobo","family":"Sellar\u00e9s","sequence":"additional","affiliation":[{"name":"Pulmonology Department, Hospital Clinic, 08402 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4027-8907","authenticated-orcid":false,"given":"Jaume","family":"Bordas-Martinez","sequence":"additional","affiliation":[{"name":"Pulmonology Department, Hospital General de Granollers, 08402 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Althobiani, M.A., Russell, A.M., Jacob, J., Ranjan, Y., Folarin, A.A., Hurst, J.R., and Porter, J.C. (2024). Interstitial lung disease: A review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1296890"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","volume":"165","author":"Travis","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2500158","DOI":"10.1183\/13993003.00158-2025","article-title":"Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS\/ATS Statement","volume":"66","author":"Ryerson","year":"2025","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2300404","DOI":"10.1183\/13993003.00404-2023","article-title":"Treatable traits: A comprehensive precision medicine approach in interstitial lung disease","volume":"62","author":"Khor","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2402418","DOI":"10.1183\/13993003.02418-2024","article-title":"Decoding the complexity: Mechanistic insights into comorbidities in idiopathic pulmonary fibrosis","volume":"65","author":"Selman","year":"2025","journal-title":"Eur. Respir. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e001291","DOI":"10.1136\/bmjresp-2022-001291","article-title":"Incidence and prevalence of interstitial lung diseases worldwide: A systematic literature review","volume":"10","author":"Koteci","year":"2023","journal-title":"BMJ Open Respir. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zeng, Q., and Jiang, D. (2023). Global trends of interstitial lung diseases from 1990 to 2019: An age-period-cohort study based on the Global Burden of Disease study 2019, and projections until 2030. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1141372"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lee, J.H., Park, H.J., Kim, S., Kim, Y.J., and Kim, H.C. (2023). Epidemiology and comorbidities in idiopathic pulmonary fibrosis: A nationwide cohort study. BMC Pulm. Med., 23.","DOI":"10.1186\/s12890-023-02340-8"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"210206","DOI":"10.1183\/16000617.0206-2021","article-title":"Incidental discovery of interstitial lung disease: Diagnostic approach, surveillance and perspectives","volume":"31","author":"Tomassetti","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chiew, S.Y., Mohammed, M., and Ong, S.C. (2025). Economic burden and cost drivers of interstitial lung disease: A systematic review. Eur. J. Health Econ.","DOI":"10.1007\/s10198-025-01836-w"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12931-022-01976-0","article-title":"Epidemiology, healthcare utilization, and related costs among patients with IPF: Results from a German claims database analysis","volume":"23","author":"Kreuter","year":"2022","journal-title":"Respir. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s40273-023-01278-3","article-title":"Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study)","volume":"41","author":"Villar","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1007\/s12325-023-02701-z","article-title":"Burden of Disease and Productivity Loss in the European Economic Area in Patients Affected by Fibrosing Interstitial Lung Disease","volume":"40","author":"Castello","year":"2023","journal-title":"Adv. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic Pulmonary Fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"160027","DOI":"10.1183\/16000617.0027-2016","article-title":"Comorbidities in interstitial lung diseases","volume":"26","author":"Margaritopoulos","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12931-018-0769-0","article-title":"Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases\u2014A claims data analysis","volume":"19","author":"Schwarzkopf","year":"2018","journal-title":"Respir. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2213-2600(18)30339-4","article-title":"Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: Results from the open-label extension study, INPULSIS-ON","volume":"7","author":"Crestani","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/13993003.00026-2015","article-title":"Pirfenidone for idiopathic pulmonary fibrosis: Analysis of pooled data from three multinational phase 3 trials","volume":"47","author":"Noble","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s12325-019-00992-9","article-title":"Management of Fibrosing Interstitial Lung Diseases","volume":"36","author":"Maher","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7525-3-61","article-title":"Patients\u2019 perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives","volume":"3","author":"Swigris","year":"2005","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Russell, A.M., Ripamonti, E., and Vancheri, C. (2016). Qualitative European survey of patients with idiopathic pulmonary fibrosis: Patients\u2019 perspectives of the disease and treatment. BMC Pulm. Med., 16.","DOI":"10.1186\/s12890-016-0171-y"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Moor, C.C., Heukels, P., Kool, M., and Wijsenbeek, M.S. (2017). Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis. Front. Med., 4.","DOI":"10.3389\/fmed.2017.00226"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"230101","DOI":"10.1183\/20734735.0101-2023","article-title":"Holistic management of patients with progressive pulmonary fibrosis","volume":"19","author":"Oliveira","year":"2023","journal-title":"Breathe"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41533-025-00462-6","article-title":"The benefits of a rapid diagnostic primary care circuit for interstitial lung disease","volume":"35","author":"Bermudo","year":"2025","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kreuter, M., Ehlers-Tenenbaum, S., Palmowski, K., Bruhwyler, J., Oltmanns, U., Muley, T., Heussel, C.P., Warth, A., Kolb, M., and Herth, F.J.F. (2016). Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151425"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1801914","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.chest.2024.04.025","article-title":"Pulmonary Hypertension in Interstitial Lung Disease: A Systematic Review and Meta-Analysis","volume":"166","author":"Ang","year":"2024","journal-title":"Chest"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Raghu, G., Sahay, S., Price, L.C., Weatherald, J., Rayner, S.G., Behr, J., Boucly, A., Das, M., McLaughlin, V., and Rahaghi, F. (2026). Pulmonary Hypertension Associated With Interstitial Lung Disease: State-of-the-Art Review. Eur. Respir. J., 2502651.","DOI":"10.1183\/13993003.02651-2025"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","article-title":"Pulmonary hypertension associated with lung disease: New insights into pathomechanisms, diagnosis, and management","volume":"11","author":"Olsson","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1164\/rccm.201101-0138OC","article-title":"Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis","volume":"184","author":"Lee","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106309","DOI":"10.1016\/j.rmed.2021.106309","article-title":"Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study","volume":"178","author":"Baqir","year":"2021","journal-title":"Respir. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00101212","article-title":"Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients","volume":"42","author":"Savarino","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1183\/09031936.06.00037005","article-title":"High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis","volume":"27","author":"Raghu","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1513\/AnnalsATS.202102-172OC","article-title":"Antacid Medication and Antireflux Surgery in Patients with Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis","volume":"19","author":"Khor","year":"2022","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2201585","DOI":"10.1183\/13993003.01585-2022","article-title":"The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: A bidirectional two-sample Mendelian randomisation study","volume":"61","author":"Reynolds","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"106768","DOI":"10.1016\/j.sleep.2025.106768","article-title":"Sleep apnea in interstitial lung disease: A systematic review and meta-analysis of prevalence, severity, and risk factors","volume":"136","author":"Sun","year":"2025","journal-title":"Sleep Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.arbres.2023.07.017","article-title":"Characterization of Sleep-Disordered Breathing in Idiopathic Pulmonary Fibrosis","volume":"59","author":"Salord","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s11325-022-02686-z","article-title":"Sleep-related breathing disorders in idiopathic pulmonary fibrosis are frequent and may be associated with pulmonary vascular involvement","volume":"27","author":"Hagmeyer","year":"2023","journal-title":"Sleep Breath."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1378\/chest.08-2776","article-title":"Obstructive sleep apnea is common in idiopathic pulmonary fibrosis","volume":"136","author":"Lancaster","year":"2009","journal-title":"Chest"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.chest.2023.05.013","article-title":"Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients with Progressive Fibrotic Interstitial Lung Disease","volume":"164","author":"Myall","year":"2023","journal-title":"Chest"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00408-017-0031-4","article-title":"OSA and Prolonged Oxygen Desaturation During Sleep are Strong Predictors of Poor Outcome in IPF","volume":"195","author":"Bosi","year":"2017","journal-title":"Lung"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5664\/jcsm.2758","article-title":"Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis","volume":"9","author":"Kolilekas","year":"2013","journal-title":"J. Clin. Sleep Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5664\/jcsm.8932","article-title":"Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: Differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment","volume":"17","author":"Papadogiannis","year":"2021","journal-title":"J. Clin. Sleep Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11325-014-1033-6","article-title":"Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Mermigkis","year":"2015","journal-title":"Sleep Breath."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11325-010-0476-7","article-title":"CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea--therapeutic difficulties and dilemmas","volume":"16","author":"Mermigkis","year":"2012","journal-title":"Sleep Breath."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12931-024-02871-6","article-title":"Treating sleep-disordered breathing of idiopathic pulmonary fibrosis patients with CPAP and nocturnal oxygen treatment. A pilot study: Sleep-disordered breathing treatment in IPF","volume":"25","author":"Salord","year":"2024","journal-title":"Respir. Res."},{"key":"ref_56","first-page":"584","article-title":"Effect of oxygen on sleep and breathing in patients with interstitial lung disease at moderate altitude","volume":"68","year":"2001","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"240025","DOI":"10.1183\/16000617.0025-2024","article-title":"Supplemental oxygen for symptomatic relief in people with serious respiratory illness: A systematic review and meta-analysis","volume":"34","author":"Ahmadi","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ballester, B., Milara, J., and Cortijo, J. (2019). Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030593"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2019.04.114","article-title":"Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer","volume":"156","author":"Tzouvelekis","year":"2019","journal-title":"Chest"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1513\/AnnalsATS.201807-481OC","article-title":"Idiopathic Pulmonary Fibrosis and Lung Cancer. A Systematic Review and Meta-analysis","volume":"16","author":"Brown","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Wang, H., Yang, R., Jin, J., Wang, Z., and Li, W. (2021). Impact of concomitant idiopathic pulmonary fibrosis on prognosis in lung cancer patients: A meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0259784"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jacr.2022.06.018","article-title":"Fleischner Society Guideline Recommendations for Incidentally Detected Pulmonary Nodules and the Probability of Lung Cancer","volume":"19","author":"Farjah","year":"2022","journal-title":"J. Am. Coll. Radiol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force, Krist, A.H., Davidson, K.W., Mangione, C.M., Barry, M.J., Cabana, M., Caughey, A.B., Davis, E.M., Donahue, K.E., and Doubeni, C.A. (2021). Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 325, 962\u2013970.","DOI":"10.1001\/jama.2021.1117"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00595-010-4384-z","article-title":"Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography","volume":"41","author":"Suzuki","year":"2011","journal-title":"Surg. Today"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000357046","article-title":"Postoperative pulmonary complications after surgery in patients with interstitial lung disease","volume":"87","author":"Choi","year":"2014","journal-title":"Respiration"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MCP.0000000000000977","article-title":"Management of patients with idiopathic pulmonary fibrosis and lung cancer: Challenges in clinical practice","volume":"29","author":"Karampitsakos","year":"2023","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"00897-2020","DOI":"10.1183\/23120541.00897-2020","article-title":"IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome","volume":"7","author":"Shull","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_68","first-page":"815","article-title":"Coronary artery calcium score is a prognostic factor for mortality in idiopathic pulmonary fibrosis","volume":"114","author":"Caminati","year":"2023","journal-title":"Minerva Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Cabrera-C\u00e9sar, E., Fern\u00e1ndez-Jim\u00e9nez, R., Lopez-Garcia, J., Sanmart\u00edn-S\u00e1nchez, A., Ben\u00edtez Cano-Gamonoso, M., Asschert Ag\u00fcero, I., Esp\u00edldora-Hern\u00e1ndez, F., Garcia, L.F.d.R., Vega-Aguilar, I., and Amaya-Campos, M.d.M. (2025). Malnutrition, Sarcopenia, and Malnutrition Sarcopenia Syndrome in Idiopathic Pulmonary Fibrosis. Adv. Respir. Med., 93.","DOI":"10.3390\/arm93030011"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"240126","DOI":"10.1183\/16000617.0126-2024","article-title":"Sarcopenia in interstitial lung disease","volume":"33","author":"Sheehy","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Kanjrawi, A.A., Mathers, L., Webster, S., Corte, T.J., and Carey, S. (2021). Nutritional status and quality of life in interstitial lung disease: A prospective cohort study. BMC Pulm. Med., 21.","DOI":"10.1186\/s12890-021-01418-5"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1038\/s41598-018-32478-z","article-title":"Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis","volume":"8","author":"Suzuki","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Krauss, E., Tello, S., Kuhlewey, D., Mahavadi, P., Scharmer, C., Behr, J., Guenther, A., and Huss, G. (2025). The Patient Journey in Interstitial Lung Disease: Mobility, Independence, and Psychological Burden. J. Clin. Med., 14.","DOI":"10.3390\/jcm14248697"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of Fibrotic Lung Diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa2503643","article-title":"Nerandomilast in Patients with Progressive Pulmonary Fibrosis","volume":"392","author":"Maher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Nathan, S.D., Smith, P., Deng, C., De Salvo, M., Wuyts, W., Pavie-Gallegos, J., Song, J.W., Kramer, M.R., King, C.S., and Mackintosh, J.A. (2026). Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis. N. Engl. J. Med., Epub ahead of printing.","DOI":"10.1056\/NEJMoa2512911"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"100124","DOI":"10.1016\/j.chpulm.2024.100124","article-title":"Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary Fibrosis","volume":"3","author":"Nathan","year":"2025","journal-title":"CHEST Pulm."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/jama.2023.5355","article-title":"Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials","volume":"329","author":"Maher","year":"2023","journal-title":"JAMA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.2024.8693","article-title":"Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial","volume":"332","author":"Raghu","year":"2024","journal-title":"JAMA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MCP.0000000000001089","article-title":"Evidence from recent clinical trials in fibrotic interstitial lung diseases","volume":"30","author":"Cottin","year":"2024","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"104481","DOI":"10.1016\/j.ebiom.2023.104481","article-title":"Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: Results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability","volume":"90","author":"Nambiar","year":"2023","journal-title":"eBioMedicine"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"210017","DOI":"10.1183\/16000617.0017-2021","article-title":"Lung transplantation for interstitial lung disease","volume":"30","author":"Kapnadak","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"100054","DOI":"10.1016\/j.jhlto.2024.100054","article-title":"Outcomes of lung transplantation in patients with telomere-related forms of progressive fibrosing interstitial lung disease pulmonary fibrosis: A systematic review","volume":"3","author":"Miedema","year":"2024","journal-title":"JHLT Open"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1513\/AnnalsATS.202304-391CME","article-title":"Supplemental Oxygen Therapy in Interstitial Lung Disease: A Narrative Review","volume":"20","author":"Clark","year":"2023","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1164\/rccm.202009-3608ST","article-title":"Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline","volume":"202","author":"Jacobs","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/thoraxjnl-2015-206918","article-title":"Guideline update: The British Thoracic Society Guidelines on home oxygen use in adults","volume":"70","author":"Hardinge","year":"2015","journal-title":"Thorax"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Badenes-Bonet, D., Cejudo, P., Rod\u00f3-Pin, A., Mart\u00edn-Ontiyuelo, C., Chalela, R., Rodr\u00edguez-Portal, J.A., V\u00e1zquez-S\u00e1nchez, R., Gea, J., Duran, X., and Caguana, O.A. (2021). Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: A pilot crossover clinical trial. BMC Pulm. Med., 21.","DOI":"10.1186\/s12890-021-01727-9"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/resp.12650","article-title":"Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia","volume":"21","author":"Troy","year":"2016","journal-title":"Respirology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2213-2600(26)00005-6","article-title":"Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): A multicentre, randomised, sham-controlled trial","volume":"14","author":"Holland","year":"2026","journal-title":"Lancet Respir. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","article-title":"Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): A prospective, open-label, mixed-method, crossover randomised controlled trial","volume":"6","author":"Visca","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2202014","DOI":"10.1183\/13993003.02014-2022","article-title":"European Respiratory Society clinical practice guideline: Palliative care for people with COPD or interstitial lung disease","volume":"62","author":"Janssen","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1177\/10499091241227556","article-title":"Perceptions on Use of Opioids in Palliative Care of Dyspnoea in Patients with Fibrotic interstitial lung disease and Chronic Obstructive Pulmonary Disease: A Qualitative Study","volume":"41","author":"Hvelplund","year":"2024","journal-title":"Am. J. Hosp. Palliat. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2301956","DOI":"10.1183\/13993003.01956-2023","article-title":"Opioids for dyspnoea in interstitial lung disease: Does the sequence and timing of therapy matter?","volume":"64","author":"Kalluri","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-2600(23)00432-0","article-title":"Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): A prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial","volume":"12","author":"Wu","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/SPC.0000000000000753","article-title":"Cough and dyspnea management in pulmonary fibrosis","volume":"19","author":"Wijsenbeek","year":"2025","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4046\/trd.2025.0136","article-title":"Non-pharmacological Management of Fibrosing Interstitial Lung Diseases","volume":"89","author":"Kaenmuang","year":"2025","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/17476348.2025.2453657","article-title":"Challenges of symptom management in interstitial lung disease: Dyspnea, cough, and fatigue","volume":"19","author":"Pascoe","year":"2025","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_99","first-page":"CD006322","article-title":"Pulmonary rehabilitation for interstitial lung disease","volume":"2","author":"Dowman","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1164\/rccm.202306-1066ST","article-title":"Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline","volume":"208","author":"Rochester","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000370126","article-title":"Principles of rehabilitation and reactivation: Interstitial lung disease, sarcoidosis and rheumatoid disease with respiratory involvement","volume":"89","author":"Holland","year":"2015","journal-title":"Respiration"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Cerd\u00e1n-De-las-heras, J., Balbino, F., L\u00f8kke, A., Catal\u00e1n-Matamoros, D., Hilberg, O., and Bendstrup, E. (2021). Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis-A Single-Center Randomized Trial. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph181910016"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2566868","DOI":"10.1080\/07853890.2025.2566868","article-title":"Benefits of different characteristics of pulmonary rehabilitation programs in patients with interstitial lung disease: A systematic review and meta-analysis","volume":"57","author":"Chen","year":"2025","journal-title":"Ann. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1378\/chest.10-0608","article-title":"Depression and functional status are strongly associated with dyspnea in interstitial lung disease","volume":"139","author":"Ryerson","year":"2011","journal-title":"Chest"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/resp.12360","article-title":"Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease","volume":"19","author":"Holland","year":"2014","journal-title":"Respirology"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Tzouvelekis, A., Karampitsakos, T., Kourtidou, S., Bouros, E., Tzilas, V., Katsaras, M., Antonou, C., Dassiou, M., and Bouros, D. (2020). Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00029"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Lee, Y.J., Choi, S.M., Lee, Y.J., Cho, Y.J., Yoon HIl Lee, J.H., Lee, C.-T., and Park, J.S. (2017). Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184300"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1700168","DOI":"10.1183\/13993003.00168-2017","article-title":"Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis","volume":"50","author":"Glaspole","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"S2238","DOI":"10.21037\/jtd.2019.10.23","article-title":"Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation","volume":"11","author":"Pumar","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-2600(22)00387-3","article-title":"Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): A randomised controlled trial","volume":"11","author":"Kahlmann","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/resp.14859","article-title":"A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial","volume":"30","author":"Solomon","year":"2024","journal-title":"Respirology"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Pouptsis, A., Zaragoz\u00e1, R., Garc\u00eda-Trevijano, E.R., Vi\u00f1a, J.R., and Ortiz-Zapater, E. (2025). Nutrition, Lifestyle, and Environmental Factors in Lung Homeostasis and Respiratory Health. Nutrients, 17.","DOI":"10.3390\/nu17060954"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.resinv.2017.09.004","article-title":"Physical activity in daily life in patients with idiopathic pulmonary fibrosis","volume":"56","author":"Nishiyama","year":"2018","journal-title":"Respir. Investig."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"808260","DOI":"10.1155\/2012\/808260","article-title":"Smoking and Idiopathic Pulmonary Fibrosis","volume":"2012","author":"Oh","year":"2012","journal-title":"Pulm. Med."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Mariscal-Aguilar, P., G\u00f3mez-Carrera, L., Bonilla, G., D\u00edaz-Almir\u00f3n, M., Gay\u00e1, F., Carpio, C., Zamarr\u00f3n, E., Fern\u00e1ndez-Velilla, M., Torres, I., and Esteban, I. (2023). Air pollution exposure and its effects on idiopathic pulmonary fibrosis: Clinical worsening, lung function decline, and radiological deterioration. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1135162"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1159\/000544919","article-title":"Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS\/ETS, SIMIT, SIP\/IRS, and SItI","volume":"104","author":"Micheletto","year":"2025","journal-title":"Respiration"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/17476348.2025.2528947","article-title":"Addressing advance care planning for idiopathic pulmonary fibrosis: A call to action","volume":"19","author":"Calypso","year":"2025","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/10499091221083575","article-title":"Impact of Palliative Care in End-of-Life of Fibrotic Interstitial Lung Disease Patients","volume":"39","author":"Chai","year":"2022","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"107659","DOI":"10.1016\/j.rmed.2024.107659","article-title":"Patient and caregiver shared experiences of pulmonary fibrosis (PF): A systematic literature review","volume":"227","author":"Wells","year":"2024","journal-title":"Respir. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MCP.0000000000000703","article-title":"Burden of idiopathic pulmonary fibrosis on patients\u2019 emotional well being and quality of life: A literature review","volume":"26","author":"Antoniou","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"190125","DOI":"10.1183\/16000617.0125-2019","article-title":"The supportive care needs of people living with pulmonary fibrosis and their caregivers: A systematic review","volume":"29","author":"Lee","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.hrtlng.2018.03.004","article-title":"Burden, resilience and coping in caregivers of patients with interstitial lung disease","volume":"47","author":"Shah","year":"2018","journal-title":"Heart Lung"},{"key":"ref_127","first-page":"5","article-title":"Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study","volume":"88","author":"Magnani","year":"2017","journal-title":"Acta Biomed."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S2213-2600(20)30067-9","article-title":"Patient support groups are a lifeline for those with idiopathic pulmonary fibrosis","volume":"8","author":"Almond","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Kaneko, Y., Waseda, Y., Yasuoka, H., Okazaki, M., Nagata, S., Iwasaki, R., Small, M., and Ishii, H. (2025). The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: A cross-sectional survey. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1526530"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"240176","DOI":"10.1183\/16000617.0176-2024","article-title":"Health disparities and associated social determinants of health in interstitial lung disease: A narrative review","volume":"34","author":"Tikellis","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2213-2600(22)00228-4","article-title":"Home monitoring in interstitial lung diseases","volume":"11","author":"Wijsenbeek","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1164\/rccm.202410-2080ST","article-title":"Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement","volume":"211","author":"Khor","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"01234-2024","DOI":"10.1183\/23120541.01234-2024","article-title":"Online home spirometry in national pulmonary fibrosis care: Insights from daily practice","volume":"11","author":"Nakshbandi","year":"2025","journal-title":"ERJ Open Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/resp.14874","article-title":"Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD (RE-BUILD) pilot study","volume":"30","author":"Glenn","year":"2025","journal-title":"Respirology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e002067","DOI":"10.1136\/bmjresp-2023-002067","article-title":"REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease","volume":"11","author":"Barth","year":"2024","journal-title":"BMJ Open Respir. Res."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Nakshbandi, G., Moor, C.C., Antoniou, K., Cottin, V., Hoffmann-Vold, A.M., Koemans, E.A., Kreuter, M., Molyneaux, P.L., Wuyts, W.A., and Wijsenbeek, M.S. (2023). Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE. BMC Pulm. Med., 23.","DOI":"10.1186\/s12890-023-02336-4"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Althobiani, M.A., and Almoagal, M. (2025). Remote patient monitoring in autoimmune related interstitial lung diseases: A narrative review. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1643176"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Baiges, M., Iglesias, D., Persentili, S., Jim\u00e9nez, M., Ortega, P., and Bordas-Martinez, J. (2025). A Pragmatic Tele-Nursing Program Improves Satisfaction of Patients with Pulmonary Fibrosis and Their Caregivers-A Pilot Study. Medicina, 61.","DOI":"10.3390\/medicina61081385"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.resinv.2025.09.007","article-title":"Artificial intelligence for diagnosis in interstitial lung disease and digital ontology for unclassified interstitial lung disease","volume":"63","author":"Baba","year":"2025","journal-title":"Respir. Investig."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Marchi, G., Fanni, S.C., Mercier, M., Cefalo, J., Salerni, C., Ferioli, M., Candoli, P., Romei, C., Gori, L., and Cucchiara, F. (2025). Artificial intelligence and radiomics in drug-induced interstitial lung disease. ERJ Open Res.","DOI":"10.1183\/23120541.01150-2025"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/RLI.0000000000000974","article-title":"Artificial Intelligence and Interstitial Lung Disease: Diagnosis and Prognosis","volume":"58","author":"Dack","year":"2023","journal-title":"Investig. Radiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s11547-025-02067-y","article-title":"Unlocking the potential of radiomics in identifying fibrosing and inflammatory patterns in interstitial lung disease","volume":"130","author":"Colligiani","year":"2025","journal-title":"La Radiol. Medica"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.hrtlng.2025.10.023","article-title":"A journey without a map: Qualitative insights into the diagnosis of idiopathic pulmonary fibrosis","volume":"75","author":"Sowicz","year":"2026","journal-title":"Heart Lung"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e098770","DOI":"10.1136\/bmjopen-2025-098770","article-title":"Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: A sequential exploratory mixed methods research protocol","volume":"15","author":"Chu","year":"2025","journal-title":"BMJ Open"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.arbres.2021.09.012","article-title":"Racial Disparities in Pulmonary Fibrosis and the Impact on the Black Population","volume":"58","author":"Adegunsoye","year":"2021","journal-title":"Arch. Bronconeumol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Figueiredo, R.G., Duarte, N.F.V., Campos, D.C.B., de Jesus Diaz Verduzco, M., M\u00e1rquez, \u00c1.A., de Araujo, G.T.B., and Rubin, A.S. (2024). Improving Accessibility to Patients with Interstitial Lung Disease (ILD): Barriers to Early Diagnosis and Timely Treatment in Latin America. Int. J. Environ. Res. Public Health, 21.","DOI":"10.20944\/preprints202403.1263.v2"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/eurpub\/ckv043","article-title":"Health literacy in Europe: Comparative results of the European health literacy survey (HLS-EU)","volume":"25","author":"Pelikan","year":"2015","journal-title":"Eur. J. Public Health"},{"key":"ref_148","first-page":"1","article-title":"Spain: Health System Review","volume":"26","year":"2024","journal-title":"Health Syst. Transit."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Glenn, L.M., Troy, L.K., and Corte, T.J. (2022). Diagnosing interstitial lung disease by multidisciplinary discussion: A review. Front. Med., 9.","DOI":"10.3389\/fmed.2022.1017501"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12931-025-03146-4","article-title":"Person-centred health outcomes in the routine care for people with progressive pulmonary fibrosis: The COCOS-IPF project\u2019s European survey on healthcare professionals\u2019 views and practices","volume":"26","author":"Somogyi","year":"2025","journal-title":"Respir. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12931-024-02997-7","article-title":"Patient-centered care in pulmonary fibrosis: Access, anticipate, and act","volume":"25","author":"Hofman","year":"2024","journal-title":"Respir. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.chest.2020.03.037","article-title":"Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype","volume":"158","author":"Inoue","year":"2020","journal-title":"Chest"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MCP.0000000000001199","article-title":"Moving past multidisciplinary discussions and Gender-Age-Physiology model: Precision medicine through biological phenotyping in interstitial lung disease","volume":"31","author":"Maddali","year":"2025","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2102146","DOI":"10.1183\/13993003.02146-2021","article-title":"The role of precision medicine in interstitial lung disease","volume":"60","author":"Maher","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"00872-2025","DOI":"10.1183\/23120541.00872-2025","article-title":"The COCOS-IPF core outcome set for idiopathic pulmonary fibrosis\/progressive pulmonary fibrosis care: A mixed-method multi-perspective approach","volume":"12","author":"Breuls","year":"2026","journal-title":"ERJ Open Res."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/817\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:52:02Z","timestamp":1777053122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":155,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050817"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050817","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}